Therapeutic Asset Ratings

461 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Sasanlimab Head And Neck Cancer	Pfizer	P1	D (28)
Sasanlimab Melanoma	Pfizer	P1	D (28)
Sasanlimab Ovarian Carcinoma	Pfizer	P1	D (28)
Sasanlimab Peripheral T-Cell Lymphoma, Not Otherwise Specified	Pfizer	P1	D (28)
Sasanlimab Squamous Cell Carcinoma	Pfizer	P1	D (28)
Sasanlimab Ovarian Cancer	Pfizer	P1	D (27)
Sasanlimab Gastric Cancer	Pfizer	P1	D (26)
Sasanlimab Colorectal Cancer	Pfizer	P1	D (24)
BHV3000 Migraine Disorder	Pfizer	P3	NR (0)
pf-08653944 Type 2 Diabetes Mellitus	Pfizer	P3	NR (0)
Lorviqua Non-Small Cell Lung Carcinoma	Pfizer		NR (0)

Showing 451 to 461 of 461 assets

PreviousPage 19 of 19Next